KLF14 and metabolic disease: Several KLF14 variants have been identified using genome-wide association studies (GWASs), which lead toward the altered insulin sensitivity, development, and progression of several metabolic diseases, including DM, myocardial infarction, atherosclerotic cardiac diseases, and ischemic stroke [15,16,17,18].